Literature DB >> 20640885

Development of a BAC vector for integration-independent and tight regulation of transgenes in rodents via the Tet system.

Kai Schönig1, David Kentner, Manfred Gossen, Tina Baldinger, Jun Miao, Katrin Welzel, Andreas Vente, Dusan Bartsch, Hermann Bujard.   

Abstract

The establishment of functional transgenic mouse lines is often limited by problems caused by integration site effects on the expression construct. Similarly, tetracycline (Tet) controlled transcription units most commonly used for conditional transgene expression in mice are strongly influenced by their genomic surrounding. Using bacterial artificial chromosome (BAC) technology in constitutive expression systems, it has been shown that integration site effects resulting in unwanted expression patterns can be largely eliminated. Here we describe a strategy to minimize unfavourable integration effects on conditional expression constructs based on a 75 kb genomic BAC fragment. This fragment was derived from a transgenic mouse line, termed LC-1, which carries the Tet-inducible genes luciferase and cre (Schönig et al. 2002). Animals of this mouse line have previously been shown to exhibit optimal expression properties in terms of tightness in the off state and the absolute level of induction, when mated to appropriate transactivator expressing mice. Here we report the cloning and identification of the transgenic LC-1 integration site which was subsequently inserted into a bacterial artificial chromosome. We demonstrate that this vector facilitates the efficient generation of transgenic mouse and rat lines, where the Tet-controlled expression unit is shielded from perturbations caused by the integration site.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640885     DOI: 10.1007/s11248-010-9427-0

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  62 in total

1.  Development of stable cell lines for production or regulated expression using matrix attachment regions.

Authors:  M Zahn-Zabal; M Kobr; P A Girod; M Imhof; P Chatellard; M de Jesus; F Wurm; N Mermod
Journal:  J Biotechnol       Date:  2001-04-27       Impact factor: 3.307

2.  Multiple new and isolated families within the mouse superfamily of V1r vomeronasal receptors.

Authors:  Ivan Rodriguez; Karina Del Punta; Andrea Rothman; Tomohiro Ishii; Peter Mombaerts
Journal:  Nat Neurosci       Date:  2002-02       Impact factor: 24.884

3.  Generating conditional mouse mutants via tetracycline-controlled gene expression.

Authors:  Kai Schönig; Hermann Bujard
Journal:  Methods Mol Biol       Date:  2003

4.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  BAC engineering for the generation of ES cell-targeting constructs and mouse transgenes.

Authors:  Giuseppe Testa; Kristina Vintersten; Youming Zhang; Vladmir Benes; Joep P P Muyrers; A Francis Stewart
Journal:  Methods Mol Biol       Date:  2004

6.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

7.  Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.

Authors:  Ernesto Bockamp; Cecilia Antunes; Marko Maringer; Rosario Heck; Katrin Presser; Sven Beilke; Svetlana Ohngemach; Rudiger Alt; Michael Cross; Rolf Sprengel; Udo Hartwig; Bernd Kaina; Steffen Schmitt; Leonid Eshkind
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

8.  Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

Authors:  Z Zhu; B Ma; R J Homer; T Zheng; J A Elias
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain.

Authors:  M Kalos; R E Fournier
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

10.  Position effect variegation and imprinting of transgenes in lymphocytes.

Authors:  Adam Williams; Nicola Harker; Eleni Ktistaki; Henrique Veiga-Fernandes; Kathleen Roderick; Mauro Tolaini; Trisha Norton; Keith Williams; Dimitris Kioussis
Journal:  Nucleic Acids Res       Date:  2008-02-22       Impact factor: 16.971

View more
  5 in total

Review 1.  2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research.

Authors:  Michael J Flister; Jeremy W Prokop; Jozef Lazar; Mary Shimoyama; Melinda Dwinell; Aron Geurts
Journal:  J Cardiovasc Transl Res       Date:  2015-04-29       Impact factor: 4.132

2.  Inducible gene manipulations in brain serotonergic neurons of transgenic rats.

Authors:  Tillmann Weber; Kai Schönig; Björn Tews; Dusan Bartsch
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

3.  Tetracycline inducible gene manipulation in serotonergic neurons.

Authors:  Tillmann Weber; Insa Renzland; Max Baur; Simon Mönks; Elke Herrmann; Verena Huppert; Frank Nürnberg; Kai Schönig; Dusan Bartsch
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

4.  A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis.

Authors:  Nicole Bäumer; Sebastian Bäumer; Miriam Haak; Steffen Koschmieder; Kai Schönig; Wolfgang E Berdel; Carsten Müller-Tidow
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

5.  Conditional gene expression systems in the transgenic rat brain.

Authors:  Kai Schönig; Tillmann Weber; Ariana Frömmig; Lena Wendler; Brigitte Pesold; Dominik Djandji; Hermann Bujard; Dusan Bartsch
Journal:  BMC Biol       Date:  2012-09-03       Impact factor: 7.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.